SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-06-001059
Filing Date
2006-01-30
Accepted
2006-01-30 16:08:30
Documents
14
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2166684z20-f.htm 20-F 2889521
2 EX-1.1 a2166684zex-1_1.htm EX-1.1 80803
3 EX-1.2 a2166684zex-1_2.htm EX-1.2 176169
4 EX-2.3 a2166684zex-2_3.htm EX-2.3 19217
5 EX-4.4 a2166684zex-4_4.htm EX-4.4 53687
6 EX-4.5 a2166684zex-4_5.htm EX-4.5 432717
7 EX-4.6 a2166684zex-4_6.htm EX-4.6 175036
8 EX-4.7 a2166684zex-4_7.htm EX-4.7 321023
9 EX-4.8 a2166684zex-4_8.htm EX-4.8 448078
10 EX-12.1 a2166684zex-12_1.htm EX-12.1 13943
11 EX-12.2 a2166684zex-12_2.htm EX-12.2 13869
12 EX-13.0 a2166684zex-13_0.htm EX-13.0 8845
13 EX-14.1 a2166684zex-14_1.htm EX-14.1 3889
14 G80915.JPG g80915.jpg GRAPHIC 3801
  Complete submission text file 0001047469-06-001059.txt   4643486
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND CH 4056
Business Address LICHSTRASSE 35 BASEL SWITZERLAND V8 CH 4056
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 06562107
SIC: 2834 Pharmaceutical Preparations